Clinical Spectrum of CADASIL and the Effect of Cardiovascular Risk Factors on Phenotype

Abstract

Our data suggest that cardiovascular risk factors may modulate the clinical expression of CADASIL. The associations with hypertension and smoking suggest that risk factors should be treated aggressively in patients with CADASIL.